NO161002C - ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE POLYPEPTIDES. - Google Patents

ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE POLYPEPTIDES.

Info

Publication number
NO161002C
NO161002C NO841540A NO841540A NO161002C NO 161002 C NO161002 C NO 161002C NO 841540 A NO841540 A NO 841540A NO 841540 A NO841540 A NO 841540A NO 161002 C NO161002 C NO 161002C
Authority
NO
Norway
Prior art keywords
preparation
active polypeptides
therapeutic active
analogue procedure
analogue
Prior art date
Application number
NO841540A
Other languages
Norwegian (no)
Other versions
NO841540L (en
NO161002B (en
Inventor
Nicola Green
Stephen Alexander
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of NO841540L publication Critical patent/NO841540L/en
Publication of NO161002B publication Critical patent/NO161002B/en
Publication of NO161002C publication Critical patent/NO161002C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1018Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16211Influenzavirus B, i.e. influenza B virus
    • C12N2760/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO841540A 1982-08-23 1984-04-17 ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE POLYPEPTIDES. NO161002C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41045582A 1982-08-23 1982-08-23
PCT/US1983/001291 WO1984000687A1 (en) 1982-08-23 1983-08-23 Broad spectrum influenza antisera

Publications (3)

Publication Number Publication Date
NO841540L NO841540L (en) 1984-04-17
NO161002B NO161002B (en) 1989-03-13
NO161002C true NO161002C (en) 1989-06-21

Family

ID=23624803

Family Applications (1)

Application Number Title Priority Date Filing Date
NO841540A NO161002C (en) 1982-08-23 1984-04-17 ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE POLYPEPTIDES.

Country Status (16)

Country Link
EP (1) EP0116629A4 (en)
JP (1) JPS59501714A (en)
KR (1) KR840006198A (en)
AU (1) AU570929B2 (en)
DK (1) DK203684A (en)
ES (1) ES8505819A1 (en)
FI (1) FI841583A0 (en)
GR (1) GR78931B (en)
IL (1) IL69556A (en)
IT (1) IT1168636B (en)
NO (1) NO161002C (en)
NZ (2) NZ205341A (en)
PH (1) PH18872A (en)
PT (1) PT77230B (en)
WO (1) WO1984000687A1 (en)
ZA (1) ZA836080B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR241713A1 (en) * 1984-08-30 1992-11-30 Smithkline Beckman Corp Vaccinal polypeptides
US5866363A (en) 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
WO1990008161A1 (en) * 1989-01-12 1990-07-26 The Blood Center Of Southeastern Wisconsin Peptide-mediated modulation of t-cell recognition as a means of affecting immune responses
EP0621339B1 (en) * 1992-09-17 2001-10-24 Takara Shuzo Co. Ltd. Immunogenic human influenza A virus haemagglutinin polypeptides
JP2996864B2 (en) * 1994-03-30 2000-01-11 寳酒造株式会社 Antibody variable region DNA
CA2652452C (en) * 2006-05-15 2018-07-31 Sea Lane Biotechnologies, Llc Neutralizing antibodies to influenza viruses
US8148085B2 (en) 2006-05-15 2012-04-03 Sea Lane Biotechnologies, Llc Donor specific antibody libraries
MX2009002174A (en) * 2006-09-07 2009-03-12 Crucell Holland Bv Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof.
ITTO20070066A1 (en) 2007-01-30 2008-07-31 Pomona Biotechnologies Llc ANTI-IDIOTYPE MONOCLONAL ANTIBODIES MIMOTOPI ANTIGENE GP 120 DI HIV
BRPI0809435A2 (en) 2007-03-27 2014-09-09 Sea Lane Biotechnologies Llc CONSTRUCTS AND LIBRARIES UNDERSTANDING ANTIBODY SUBSTITUTED LIGHT CHAIN SEQUENCES
ITTO20080204A1 (en) 2008-03-17 2009-09-18 Pomona Biotechnologies Llc MONOCLONAL ANTIBODIES ACTIONS TO REACT WITH A PLURALITY OF SUBTIPS OF THE INFLUENTIAL VIRUS A
AU2009228058A1 (en) 2008-03-28 2009-10-01 Sea Lane Biotechnologies, Llc Neutralizing molecules to viral antigens
ITTO20080398A1 (en) 2008-05-27 2009-11-28 Pomona Biotechnologies Llc MONOCLONAL ANTIBODIES HAVING PROPERTY OF HOSUBLICTIC CROSS-NEUTRALIZATION FOR INFLUENTIAL VIRUSES OF SUBTIPLE TYPE H1
ITTO20080964A1 (en) 2008-12-22 2010-06-23 Natimab Therapeutics S R L ANTI-HCV MONOCLONAL ANTIBODY AS A MEDICATION FOR THERAPEUTIC TREATMENT AND THE PREVENTION OF HCV INFECTIONS
EP2380976A4 (en) 2008-12-25 2012-11-07 Univ Osaka Human anti-human influenza virus antibody
EP3009145A1 (en) 2009-03-30 2016-04-20 Mount Sinai School of Medicine of New York University Influenza virus vaccines and uses thereof
EP2430047B1 (en) * 2009-05-13 2018-03-28 i2 Pharmaceuticals, Inc. Neutralizing molecules to influenza viruses
CA2800182A1 (en) 2009-05-26 2010-12-02 Mount Sinai School Of Medicine Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
IT1395961B1 (en) 2009-06-01 2012-11-02 Pomona Biotechnologies Llc MONOCLONAL ANTIBODIES AS A MEDICATION FOR THERAPEUTIC AND / OR PROFILACTIC TREATMENT OF INFLUENCIAL VIRUS INFECTIONS (H1N1) OF SWINE ORIGIN (S-OIV)
US9701723B2 (en) * 2010-02-18 2017-07-11 Icahn School Of Medicine At Mount Sinai Vaccines for use in the prophylaxis and treatment of influenza virus disease
CN102939103A (en) 2010-03-30 2013-02-20 西奈山医学院 Influenza virus vaccines and uses thereof
EP2736928B1 (en) 2011-07-28 2019-01-09 i2 Pharmaceuticals, Inc. Sur-binding proteins against erbb3
EP2758075B1 (en) 2011-09-20 2023-05-03 Icahn School of Medicine at Mount Sinai Influenza virus vaccines and uses thereof
WO2013096828A1 (en) 2011-12-22 2013-06-27 Sea Lane Biotechnologies, Llc Surrogate binding proteins
US9969794B2 (en) 2012-05-10 2018-05-15 Visterra, Inc. HA binding agents
AU2013362935B2 (en) 2012-12-18 2018-10-04 Icahn School Of Medicine At Mount Sinai Influenza virus vaccines and uses thereof
WO2014159960A1 (en) 2013-03-14 2014-10-02 Icahn School Of Medicine At Mount Sinai Antibodies against influenza virus hemagglutinin and uses thereof
JP2018504412A (en) 2015-01-23 2018-02-15 アイカーン スクール オブ メディシン アット マウント サイナイ Influenza virus vaccination regimen
US10513553B2 (en) 2015-11-13 2019-12-24 Visterra, Inc. Compositions and methods for treating and preventing influenza
CA3023143A1 (en) 2016-06-15 2017-12-21 Icahn School Of Medicine At Mount Sinai Influenza virus hemagglutinin proteins and uses thereof
CA3058652A1 (en) 2017-04-07 2018-10-11 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof
JP2022521819A (en) 2019-03-25 2022-04-12 ビステラ, インコーポレイテッド Compositions and Methods for Treating and Preventing Influenza

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI83662C (en) * 1980-07-17 1991-08-12 Scripps Clinic Res Diagnostic antibody and procedure for its preparation

Also Published As

Publication number Publication date
PH18872A (en) 1985-10-21
AU1947183A (en) 1984-03-07
IT1168636B (en) 1987-05-20
JPS59501714A (en) 1984-10-11
DK203684D0 (en) 1984-04-18
GR78931B (en) 1984-10-02
WO1984000687A1 (en) 1984-03-01
FI841583A (en) 1984-04-19
EP0116629A4 (en) 1987-06-29
NO841540L (en) 1984-04-17
IL69556A (en) 1988-05-31
IL69556A0 (en) 1983-11-30
IT8348868A0 (en) 1983-08-22
NZ205341A (en) 1988-07-28
PT77230A (en) 1983-09-01
DK203684A (en) 1984-04-18
ZA836080B (en) 1984-04-25
NZ220612A (en) 1988-07-28
EP0116629A1 (en) 1984-08-29
AU570929B2 (en) 1988-03-31
KR840006198A (en) 1984-11-22
ES525088A0 (en) 1985-06-16
PT77230B (en) 1986-02-04
NO161002B (en) 1989-03-13
ES8505819A1 (en) 1985-06-16
FI841583A0 (en) 1984-04-19

Similar Documents

Publication Publication Date Title
NO161002C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE POLYPEPTIDES.
NO160850C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE N- (BICYCLEIC HETEROCYCLYL) -4-PIPERIDINAMINES.
NO156785C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CYCLOBUTAN DERIVATIVES.
NO164025C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 3-IMIDAZOLYLMETHYL-TETRAHYDROCARBAZOLONE DERIVATIVES.
NO159016C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE PHENETANOLAMINE DERIVATIVES.
NO150760C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE AMINOTIAZOLES.
NO812344L (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE STEROIDS.
NO162189C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE IMIDAZOPYRIDINES.
NO165027C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVAL PROPENYL-CEPHALOSPOR COMPOUNDS.
NO161497C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 9A-AZA-9A-HOMOERYTROMYCIN DERIVATIVES.
NO161317C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE OXICAMS.
NO158876C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ADENOSIN DERIVATIVES.
NO154492C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC EFFECTIVE RELATIONS.
NO163693C (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE COMPOUNDS OF PLATINA.
NO158460C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE RELATIONS.
NO164541C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BENZIMIDAZOLD DERIVATIVES.
NO164295C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE FLUORED BENZYLTRIAZOL COMPOUNDS.
NO162817C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC EFFECTIVE 4-ARYL-4-PIPERIDINE CARBINOLS.
NO157976C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 3-PHENOXY-1-AZETIDINCARBOXAMIDES.
NO159090C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRIDOINDOL DERIVATIVES.
NO164899C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE IMIDAZOLYLINDOL COMPOUNDS.
NO873680D0 (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE SULPHONAMIDO-ETHYL COMPOUNDS.
NO163570C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ACYLAMINOMITOSANES.
NO156167C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE INDOLINON DERIVATIVES.
NO158800C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE INDENDER DERIVATIVES.